InsidersTradesSigma
Track the 큐라켐 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 큐라켐 has published 15 insider filings. The latest transaction was filed on 10 January 2025 (Purchase). Among the most active insiders: 파트너스인베스트먼트. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
15 of 15 declarations
큐라켐 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and marketing of pharmaceutical products.